Basal cell carcinoma

Sanjay Rajpara, Anthony Ormerod

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Basal cell carcinoma (BCC) is the most common form of skin cancer, predominantly affecting the head and neck, and can be diagnosed clinically in most cases. Metastasis of BCC is rare, but localised tissue invasion and destruction can lead to morbidity. Incidence of BCC increases markedly after the age of 40 years, but incidence in younger people is rising, possibly as a result of increased sun exposure. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions on treatment response/recurrence (within 1 year of therapy) in people with basal cell carcinoma? What are the effects of interventions on long-term recurrence (a minimum of 2 years after treatment) in people with basal cell carcinoma? We searched: Medline, Embase, The Cochrane Library and other important databases up to February 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 11 systematic reviews, RCTs or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: Cryotherapy/cryosurgery, curettage and cautery/electrodesiccation, fluorouracil, imiquimod 5% cream, photodynamic therapy, and surgery (conventional or Moh's micrographic surgery).
Original languageEnglish
JournalBMJ Clinical Evidence
Volume2008
Publication statusPublished - 2008

Fingerprint

Basal Cell Carcinoma
imiquimod
Mohs Surgery
Cautery
Recurrence
Cryosurgery
Cryotherapy
Curettage
Incidence
Photochemotherapy
Skin Neoplasms
Solar System
United States Food and Drug Administration
Fluorouracil
Libraries
Observational Studies
Neck
Therapeutics
Head
Organizations

Cite this

Rajpara, S., & Ormerod, A. (2008). Basal cell carcinoma. BMJ Clinical Evidence, 2008.

Basal cell carcinoma. / Rajpara, Sanjay; Ormerod, Anthony.

In: BMJ Clinical Evidence, Vol. 2008, 2008.

Research output: Contribution to journalArticle

Rajpara, S & Ormerod, A 2008, 'Basal cell carcinoma', BMJ Clinical Evidence, vol. 2008.
Rajpara S, Ormerod A. Basal cell carcinoma. BMJ Clinical Evidence. 2008;2008.
Rajpara, Sanjay ; Ormerod, Anthony. / Basal cell carcinoma. In: BMJ Clinical Evidence. 2008 ; Vol. 2008.
@article{5c570b34395e4ebeb42d5cb6fcd1227c,
title = "Basal cell carcinoma",
abstract = "INTRODUCTION: Basal cell carcinoma (BCC) is the most common form of skin cancer, predominantly affecting the head and neck, and can be diagnosed clinically in most cases. Metastasis of BCC is rare, but localised tissue invasion and destruction can lead to morbidity. Incidence of BCC increases markedly after the age of 40 years, but incidence in younger people is rising, possibly as a result of increased sun exposure. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions on treatment response/recurrence (within 1 year of therapy) in people with basal cell carcinoma? What are the effects of interventions on long-term recurrence (a minimum of 2 years after treatment) in people with basal cell carcinoma? We searched: Medline, Embase, The Cochrane Library and other important databases up to February 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 11 systematic reviews, RCTs or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: Cryotherapy/cryosurgery, curettage and cautery/electrodesiccation, fluorouracil, imiquimod 5{\%} cream, photodynamic therapy, and surgery (conventional or Moh's micrographic surgery).",
author = "Sanjay Rajpara and Anthony Ormerod",
year = "2008",
language = "English",
volume = "2008",
journal = "BMJ Clinical Evidence",
issn = "1462-3846",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Basal cell carcinoma

AU - Rajpara, Sanjay

AU - Ormerod, Anthony

PY - 2008

Y1 - 2008

N2 - INTRODUCTION: Basal cell carcinoma (BCC) is the most common form of skin cancer, predominantly affecting the head and neck, and can be diagnosed clinically in most cases. Metastasis of BCC is rare, but localised tissue invasion and destruction can lead to morbidity. Incidence of BCC increases markedly after the age of 40 years, but incidence in younger people is rising, possibly as a result of increased sun exposure. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions on treatment response/recurrence (within 1 year of therapy) in people with basal cell carcinoma? What are the effects of interventions on long-term recurrence (a minimum of 2 years after treatment) in people with basal cell carcinoma? We searched: Medline, Embase, The Cochrane Library and other important databases up to February 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 11 systematic reviews, RCTs or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: Cryotherapy/cryosurgery, curettage and cautery/electrodesiccation, fluorouracil, imiquimod 5% cream, photodynamic therapy, and surgery (conventional or Moh's micrographic surgery).

AB - INTRODUCTION: Basal cell carcinoma (BCC) is the most common form of skin cancer, predominantly affecting the head and neck, and can be diagnosed clinically in most cases. Metastasis of BCC is rare, but localised tissue invasion and destruction can lead to morbidity. Incidence of BCC increases markedly after the age of 40 years, but incidence in younger people is rising, possibly as a result of increased sun exposure. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions on treatment response/recurrence (within 1 year of therapy) in people with basal cell carcinoma? What are the effects of interventions on long-term recurrence (a minimum of 2 years after treatment) in people with basal cell carcinoma? We searched: Medline, Embase, The Cochrane Library and other important databases up to February 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 11 systematic reviews, RCTs or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: Cryotherapy/cryosurgery, curettage and cautery/electrodesiccation, fluorouracil, imiquimod 5% cream, photodynamic therapy, and surgery (conventional or Moh's micrographic surgery).

M3 - Article

VL - 2008

JO - BMJ Clinical Evidence

JF - BMJ Clinical Evidence

SN - 1462-3846

ER -